[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354983-105":59,"doc-detail-354983-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","tgf-in-tumor-development-and-progression-mechanisms-and-therapeutics","TGF-β in tumor development and progression - mechanisms and therapeutics","","Transforming growth factor beta (TGF-β) is a pleiotropic cytokine involved in cell development, proliferation, epithelial-mesenchymal transition (EMT), and immune responses via SMAD-dependent or SMAD-independent signaling. In tumors, TGF-β shows dual functions: inducing apoptosis or cell-cycle arrest in early stages while driving transformation, progression, and metastasis at advanced stages. Abundant in the tumor microenvironment, it acts as a master immune checkpoint. The review consolidates tumor-focused biology, molecular mechanisms, and therapeutic potentials, summarizing recent preclinical and clinical progress of TGF-β-targeting agents and addressing safety, efficacy, and major challenges to guide clinical translation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tgf-in-tumor-development-and-progression-mechanisms-and-therapeutics/354983/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tgf-in-tumor-development-and-progression-mechanisms-and-therapeutics/354983.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does TGF-β signaling contribute to tumors across different stages?","Question",{"text":113,"@type":114},"TGF-β acts as a tumor suppressor early by inducing apoptosis or cell-cycle arrest, while in advanced stages it promotes transformation, progression, and metastasis through multidimensional mechanisms.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What role does TGF-β play in the tumor microenvironment (TME)?",{"text":118,"@type":114},"TGF-β is abundant in the TME and functions as a master immune checkpoint, supporting impaired anti-tumor responses and influencing tumor immune interactions.",{"name":120,"@type":111,"acceptedAnswer":121},"Why are systemic TGF-β inhibitors challenging for clinical use?",{"text":122,"@type":114},"Because TGF-β is highly pleiotropic, systemic inhibition can cause off-target effects in healthy tissues, leading to adverse events and safety concerns that hinder clinical translation.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354983,1790192771,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Liu et al. Molecular Biomedicine (2026) 7:9 [https://doi.org/10.1186/s43556-026-00403-w](https://doi.org/10.1186/s43556-026-00403-w)  \nMolecular Biomedicine  \n REVIEW Open Access  \nTGF-β in tumor development  \nand progression: mechanisms and therapeutics  \nJialing Liu1†, Yiwei Wang1†, Chao Tang1†, Lulu Zhang1, Sidong Xiong1*, Jun Wang2* and Chunsheng Dong1*  \nAbstract  \nTransforming growth factor beta (TGF-β) is a pleiotropic cytokine and participates in multiple cellular processes, such as cell development, proliferation, epithelial mesenchymal transition (EMT), and immune responses through SMADdependent or SMAD-independent signaling pathways. Notably, TGF-β signaling plays a dual role in tumors, acting as a potent tumor suppressor during early tumorigenesis by inducing apoptosis or cell-cycle arrest while promoting tumor transformation, progression and metastasis in advanced stage through multidimensional mechanisms. Moreover, it is abundant and functions as a master immune checkpoint in the tumor microenvironment (TME), fostering the development of numerous targeted therapies to rectify its aberrant activity in tumors in the past decades. Thus, a comprehensive overview of the pathologic roles, molecular mechanisms and therapeutic potentials ofTGF-β signaling in tumors will benefit both the basic and clinical cancer research. Here, we review the complex biology and context-dependent functions oftheTGF-β superfamily in regard to tumor, highlighting how it regulates the latter’s development, growth, and dissemination by mainly targeting tumor cells, tumor-associated fibroblasts and various immune cells. We also summarize recent advances in the preclinical and clinical development of different typesofTGF-β-targeting agents, and discuss their therapeutic potentials and challenges as well as approaches to improve the safety and efficacy ofTGF-β pathway-targeted therapy in cancers. Through the summary of known knowledge and the latest updates, this review may provide a general picture on the biological functions ofTGF-β in tumors, and facilitate the clinical implications ofTGF-β-targeted therapy in tumor patients.  \nKeywords TGF-β signaling, Tumor microenvironment, Metastasis, Anti-tumor immunity, TGF-β-targeting therapy  \n†Jialing Liu, Yiwei Wang and Chao Tang contributed equally to this work.  \n*Correspondence:  \nSidong Xiong [sdxiong@suda.edu.cn](sdxiong@suda.edu.cn)[ ](sdxiong@suda.edu.cn)Jun Wang [jwang79@suda.edu.cn](jwang79@suda.edu.cn)[ ](jwang79@suda.edu.cn)Chunsheng Dong [chunshengdong@suda.edu.cn](chunshengdong@suda.edu.cn)  \n1 The Fourth Affiliated Hospital of Soochow University, Institutes of Biology and Medical Science, Jiangsu Key Laboratory of Infection and Immunity, MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College of Soochow University, Soochow University, Suzhou, China  \n2 Institutes of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, MOE Key Laboratory of Geriatric Diseases and Immunology, Suzhou Medical College of Soochow University, Soochow University, Suzhou, China  \nIntroduction  \nBiological signaling orchestrates fundamental physiological processes, including cell activation, growth, differentiation, and metabolism, commonly through the interaction of soluble/surface molecules and membranebound receptors. Among these mediators, TGF-β, a pleiotropic cytokine, exerts diverse functions in different cell types upon binding to its cell surface receptors, and thereby plays a critical role in both health and disease. As such, the roles ofthe TGF-β signaling and therapeutic potential of TGF-β-targeting therapies in physiological and various pathological conditions have become a major focus in both basic and clinical research fields.  \nIn regard to tumor development and progression, TGF-β exerts a context-dependent anti- or pro-tumor effect. In normal cells and tissues, activated TGF-β  \n© The Author(s) 2026. Open Access This article is licensed under a C","cbCairmy9kZ8HXIx","https://ap.wps.com/l/cbCairmy9kZ8HXIx","pdf",7369020,33,"English","# Abstract\n# Introduction","[{\"question\":\"How does TGF-β signaling contribute to tumors across different stages?\",\"answer\":\"TGF-β acts as a tumor suppressor early by inducing apoptosis or cell-cycle arrest, while in advanced stages it promotes transformation, progression, and metastasis through multidimensional mechanisms.\"},{\"question\":\"What role does TGF-β play in the tumor microenvironment (TME)?\",\"answer\":\"TGF-β is abundant in the TME and functions as a master immune checkpoint, supporting impaired anti-tumor responses and influencing tumor immune interactions.\"},{\"question\":\"Why are systemic TGF-β inhibitors challenging for clinical use?\",\"answer\":\"Because TGF-β is highly pleiotropic, systemic inhibition can cause off-target effects in healthy tissues, leading to adverse events and safety concerns that hinder clinical translation.\"}]","TGF-β in tumor development and progression - mechanisms and therapeutics | PDF",1790115230,83,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f35d91ea44647bf3edc9d98dcf735676.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/51a3632de818622494a0097a173dd32f.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/242ac8a3b8e08c35f9cc96b5d31a6d70.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58ef5a1d0c224fbe5cc008d0b6a841dd.webp",980,1301]